中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
8期
1-1,2
,共2页
输血治疗%输血安全控制%不规则抗体测试
輸血治療%輸血安全控製%不規則抗體測試
수혈치료%수혈안전공제%불규칙항체측시
Treatment of blood transfusion%Transfusion safety control%Irregular antibody test
目的：研究在选取适合的血浆给患者实施输血时，针对不规则抗体项目实施测试筛查的作用。方法于本院得到输血医治各科患者中抽出1800例，通过微柱凝胶方式在尚未输血时，针对患者进行不规则抗体测试。结果共22例测试属于阳性情况，男性6例，在总数中占据27.27%的比率，女性16例，在总数中占据72.72%的比率。18例患者曾经因为救治需要接受过输血，占据总数81.81%的比率。曾经有怀孕经历的妇女患者为14例。结论因曾经怀孕或者曾经接受过输血等原因，部分患者身体中携带有不规则的抗体，为了另血型选择能够更为匹配，杜绝输血后出现排斥，应普及输血前期对抗体实施测试的环节。
目的：研究在選取適閤的血漿給患者實施輸血時，針對不規則抗體項目實施測試篩查的作用。方法于本院得到輸血醫治各科患者中抽齣1800例，通過微柱凝膠方式在尚未輸血時，針對患者進行不規則抗體測試。結果共22例測試屬于暘性情況，男性6例，在總數中佔據27.27%的比率，女性16例，在總數中佔據72.72%的比率。18例患者曾經因為救治需要接受過輸血，佔據總數81.81%的比率。曾經有懷孕經歷的婦女患者為14例。結論因曾經懷孕或者曾經接受過輸血等原因，部分患者身體中攜帶有不規則的抗體，為瞭另血型選擇能夠更為匹配，杜絕輸血後齣現排斥，應普及輸血前期對抗體實施測試的環節。
목적：연구재선취괄합적혈장급환자실시수혈시，침대불규칙항체항목실시측시사사적작용。방법우본원득도수혈의치각과환자중추출1800례，통과미주응효방식재상미수혈시，침대환자진행불규칙항체측시。결과공22례측시속우양성정황，남성6례，재총수중점거27.27%적비솔，녀성16례，재총수중점거72.72%적비솔。18례환자증경인위구치수요접수과수혈，점거총수81.81%적비솔。증경유부잉경력적부녀환자위14례。결론인증경부잉혹자증경접수과수혈등원인，부분환자신체중휴대유불규칙적항체，위료령혈형선택능구경위필배，두절수혈후출현배척，응보급수혈전기대항체실시측시적배절。
Objective Study the effect of implementation irregular antibody screening for blood transfusion with compatible blood plasma.MethodsIn our hospital 1800 cases obtained blood transfusion treatment withdrawn subjects patients,by micro column gel way in not a blood transfusion,irregular antibody test in patients.Results A total of 22 cases tested belong to the positive situation,6 cases of male,occupy 27.27% of the rate in thetotal,16 cases of female,the ratio occupied 72.72% in total.18 patients had received blood transfusionsbecause of the need of treatment,occupy 81.81% of the total number of ratio. Once pregnant women for 14 cases of patients underwent. Conclusion Because once pregnant or had received a blood transfusion and other reasons,part of the patients body withirregular antibody,in order to make the blood type selection can be more matching,to prevent rejection episodeafter blood transfusion,blood transfusion should popularize the pre implementation testing for antibodies to link.
